A61Q19/04

AQUEOUS MIXTURES COMPRISING CELLULOSE NANOCRYSTALS AND SULFONATED POLYESTER

Aqueous mixtures can include cellulose nanocrystals and sulfonated polyester, where a glass transition temperature (T.sub.g) of the sulfonated polyester is greater than 25° C. In some instances, exemplary aqueous mixtures also include one or more additives, such as pigment. Exemplary aqueous mixtures can be applied as a film that is typically hydrophobic and resilient against water at room temperature. Upon application of warm water, such as at temperatures of from about 30° C. to about 60° C., the film can be removed with no or limited abrasion and/or with no or little removal oils.

REVERSIBLE THERMOCHROMIC/PHOTOCHROMIC COSMETIC ACTIVATOR
20180000230 · 2018-01-04 · ·

A cosmetic activator system for activating a cosmetic is provided including: an activator having an energy source configured to emit an energy pulse and a controller; and an imprinter having an imprint pattern and at least one activation element configured to be in communication with the energy source, wherein the imprinter is configured to create an imprint on the cosmetic.

REVERSIBLE THERMOCHROMIC/PHOTOCHROMIC COSMETIC ACTIVATOR
20180000230 · 2018-01-04 · ·

A cosmetic activator system for activating a cosmetic is provided including: an activator having an energy source configured to emit an energy pulse and a controller; and an imprinter having an imprint pattern and at least one activation element configured to be in communication with the energy source, wherein the imprinter is configured to create an imprint on the cosmetic.

SYSTEMS AND METHODS FOR TREATING VITILIGO
20180000760 · 2018-01-04 · ·

The present invention generally relates to systems and methods for treating vitiligo. In one set of embodiments, the present invention comprises a composition comprising pyruvic acid and/or a pyruvate salt. The composition may be formulated for application to the skin of a subject, for instance, as a gel, lotion, cream, ointment, soap, or stick. In some cases, the composition may comprise a lecithin, such as phosphatidylcholine. In certain embodiments, the lecithin is present as a liquid crystal, and/or in liposomes, micelles, or other vesicles. Other aspects of the present invention are generally directed to methods of making or using such compositions, methods of promoting such compositions, kits including such compositions, or the like.

Method of producing cosmetic skin dye
11566137 · 2023-01-31 ·

A method of producing cosmetic skin dye, including a) extracting the liquid contained in the pecan husks, b) separating the extracted liquid in oil and sediments by means of natural sedimentation, c) homogeneously mixing said sediments with oil of the pecan husks to produce said skin dye, and d) applying the cosmetic skin dye in the skin of a user. The pecan husks are obtained from an unripe pecan. A higher concentration of sediments in the homogenous mixture produces a darker shade of cosmetic dye.

INVERSE LATEX FOR A COSMETIC COMPOSITION COMBINING A SPECIFIC CHELATING AGENT AND A POLYELECTROLYTE HAVING A WEAK ACID FUNCTION
20230028316 · 2023-01-26 ·

Disclosed is a self-invertible inverse latex having an aqueous phase, including: a) a cross-linked anionic polyelectrolyte (P) including: —at least one first monomer unit derived from at least one monomer selected from the elements of the group consisting of acrylic acid, methacrylic acid, 2-carboxyethyl acrylic acid, itaconic acid, maleic acid, 3-methyl 3-[(1-oxo-2-propenyl)amino]butanoic acid, the carboxylic function of the monomers being in the free, partially salified or totally salified acid form; and —at least one monomer unit derived from a polyethylenic cross-linking monomer (AR); b) ethylenediamine disuccinic acid in the form of trisodium salt.

INVERSE LATEX FOR A COSMETIC COMPOSITION COMBINING A SPECIFIC CHELATING AGENT AND A POLYELECTROLYTE HAVING A WEAK ACID FUNCTION
20230028316 · 2023-01-26 ·

Disclosed is a self-invertible inverse latex having an aqueous phase, including: a) a cross-linked anionic polyelectrolyte (P) including: —at least one first monomer unit derived from at least one monomer selected from the elements of the group consisting of acrylic acid, methacrylic acid, 2-carboxyethyl acrylic acid, itaconic acid, maleic acid, 3-methyl 3-[(1-oxo-2-propenyl)amino]butanoic acid, the carboxylic function of the monomers being in the free, partially salified or totally salified acid form; and —at least one monomer unit derived from a polyethylenic cross-linking monomer (AR); b) ethylenediamine disuccinic acid in the form of trisodium salt.

Medicament comprising ginger root CO2 extract

The present invention belongs to the fields of pharmaceuticals and cosmetics, and concerns on the one hand a medicament for the inhibition of and refers also on the cosmetic, non-therapeutic use for the treatment of hyperpigmentation, particularly induced by sun light radiation, preferably induced by visible light radiation.

Peptide showing melanogenesis promoting activity and use thereof
11518785 · 2022-12-06 · ·

The present invention provides a peptide exhibiting melanogenesis promoting activity. A peptide according to the present invention increases the activity and expression of tyrosinase and the expression of factors involved in melanogenesis, thereby exhibiting an outstanding effect on melanogenesis. The peptide of the present invention can be used for the prevention, alleviation, and treatment of hypomelanosis. The outstanding activity and stability stated above allow the peptide of the present invention to be very favorably applied to medicines, quasi-medicines, and cosmetics.

Peptide showing melanogenesis promoting activity and use thereof
11518785 · 2022-12-06 · ·

The present invention provides a peptide exhibiting melanogenesis promoting activity. A peptide according to the present invention increases the activity and expression of tyrosinase and the expression of factors involved in melanogenesis, thereby exhibiting an outstanding effect on melanogenesis. The peptide of the present invention can be used for the prevention, alleviation, and treatment of hypomelanosis. The outstanding activity and stability stated above allow the peptide of the present invention to be very favorably applied to medicines, quasi-medicines, and cosmetics.